ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674455 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674455; 2) Community: the network communities that were significantly associated with the response to NSC 674455; 3) Molecule: the relationships between components within communities and NSC 674455; 4) MDR: the compounds that were significantly associated with the NSC 674455.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.21187639
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0480633950058475 0.27421586
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.082759453
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0480633950058475 -0.034931884
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0480633950058475 0.23836196
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 0.48405537
NSC 743532 Null 0.0480633950058475 0.038642406
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0480633950058475 0.38567879
NSC 750050 Null 0.0480633950058475 0.33281715
NSC 752346 Null 0.0480633950058475 0.17148129
Total:85  Current:84    [First] [Prev] [Next] [Last]